Salicylic acid derivatives being farnesyl pyrophosphate synthase activity inhibitors

Details for Australian Patent Application No. 2009305490 (hide)

Owner Novartis AG

Inventors Cotesta, Simona; Glickman, Joseph Fraser; Jahnke, Wolfgang; Marzinzik, Andreas; Ofner, Silvio; Rondeau, JeanMichel; Zoller, Thomas

Agent Davies Collison Cave

Pub. Number AU-A-2009305490

PCT Pub. Number WO2010/043584

Priority 08166473.2 13.10.08 EP

Filing date 12 October 2009

Wipo publication date 22 April 2010

International Classifications

C07C 65/21 (2006.01) Compounds having carboxyl groups bound to carbon atoms of six-membered aromatic rings and containing any of the groups OH, O-metal, CHO, keto, ether, groups, groups, or groups

A61K 31/192 (2006.01)

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

C07C 229/64 (2006.01) Compounds containing amino and carboxyl groups bound to the same carbon skeleton

C07D 207/06 (2006.01) Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 207/08 (2006.01) Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 209/08 (2006.01) Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 211/22 (2006.01) Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

C07D 213/74 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 231/38 (2006.01) Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings

C07D 295/10 (2006.01) Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms

C07D 307/14 (2006.01) Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom

C07D 319/08 (2006.01) Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms

C07D 333/20 (2006.01) Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom

Event Publications

10 March 2011 PCT application entered the National Phase

  PCT publication WO2010/043584 Priority application(s): WO2010/043584

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009305521-Ultra-high efficiency multi-junction solar cells using polychromatic diffractive concentrators

2009305477-Process for the preparation of optically active (S)-(-)-2- (N-propylamino)-5-methoxytetraline and (S)-(-)-2- (N-propylamino)-5-hydroxytetraline compounds